Pre-order Enquiry
Request Free Sample
Global PD-L1 Biomarker Testing Market Insights and Forecast to 2028
SKU ID : QYR-19866662 | Publishing Date : 06-Jan-2022 | No. of pages : 114
Detailed TOC of Global PD-L1 Biomarker Testing Market Insights and Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PD-L1 (22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1 (SP142)
1.2.5 PD-L1 (SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2017-2028)
2.2 PD-L1 Biomarker Testing Growth Trends by Region
2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2017-2022)
2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028)
2.3 PD-L1 Biomarker Testing Market Dynamics
2.3.1 PD-L1 Biomarker Testing Industry Trends
2.3.2 PD-L1 Biomarker Testing Market Drivers
2.3.3 PD-L1 Biomarker Testing Market Challenges
2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 Biomarker Testing Players by Revenue
3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2017-2022)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2017-2022)
3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2021
3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served
3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service
3.7 Date of Enter into PD-L1 Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2017-2022)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028)
5 PD-L1 Biomarker Testing Breakdown Data by Application
5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2017-2022)
5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PD-L1 Biomarker Testing Market Size (2017-2028)
6.2 North America PD-L1 Biomarker Testing Market Size by Type
6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
6.3 North America PD-L1 Biomarker Testing Market Size by Application
6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
6.4 North America PD-L1 Biomarker Testing Market Size by Country
6.4.1 North America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PD-L1 Biomarker Testing Market Size (2017-2028)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022)
7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028)
7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2017-2028)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022)
7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028)
7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2017-2028)
7.4 Europe PD-L1 Biomarker Testing Market Size by Country
7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022)
7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2017-2028)
8.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PD-L1 Biomarker Testing Market Size (2017-2028)
9.2 Latin America PD-L1 Biomarker Testing Market Size by Type
9.2.1 Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
9.2.2 Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
9.2.3 Latin America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
9.3 Latin America PD-L1 Biomarker Testing Market Size by Application
9.3.1 Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
9.3.2 Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
9.3.3 Latin America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
9.4 Latin America PD-L1 Biomarker Testing Market Size by Country
9.4.1 Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
9.4.2 Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2017-2028)
10.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.1.5 Agilent Technologies Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 Biomarker Testing Introduction
11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck PD-L1 Biomarker Testing Introduction
11.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
11.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction
11.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 Ono Pharmaceutical
11.6.1 Ono Pharmaceutical Company Details
11.6.2 Ono Pharmaceutical Business Overview
11.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction
11.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.6.5 Ono Pharmaceutical Recent Developments
11.7 Regeneron
11.7.1 Regeneron Company Details
11.7.2 Regeneron Business Overview
11.7.3 Regeneron PD-L1 Biomarker Testing Introduction
11.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.7.5 Regeneron Recent Developments
11.8 Innovent
11.8.1 Innovent Company Details
11.8.2 Innovent Business Overview
11.8.3 Innovent PD-L1 Biomarker Testing Introduction
11.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.8.5 Innovent Recent Developments
11.9 Hengrui Medicine
11.9.1 Hengrui Medicine Company Details
11.9.2 Hengrui Medicine Business Overview
11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction
11.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.9.5 Hengrui Medicine Recent Developments
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Details
11.10.2 Junshi Biosciences Business Overview
11.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction
11.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022)
11.10.5 Junshi Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global PD-L1 Biomarker Testing Market Insights and Forecast to 2028
List of TablesTable 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PD-L1 (22C3)
Table 3. Key Players of PD-L1(28-8)
Table 4. Key Players of PD-L1 (SP142)
Table 5. Key Players of PD-L1 (SP263)
Table 6. Key Players of Other
Table 7. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2017-2022)
Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2023-2028)
Table 13. PD-L1 Biomarker Testing Market Trends
Table 14. PD-L1 Biomarker Testing Market Drivers
Table 15. PD-L1 Biomarker Testing Market Challenges
Table 16. PD-L1 Biomarker Testing Market Restraints
Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global PD-L1 Biomarker Testing Revenue Share by Players (2017-2022)
Table 19. Global Top PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
Table 20. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players PD-L1 Biomarker Testing Product Solution and Service
Table 24. Date of Enter into PD-L1 Biomarker Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2017-2022)
Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2023-2028)
Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global PD-L1 Biomarker Testing Revenue Share by Application (2017-2022)
Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global PD-L1 Biomarker Testing Revenue Share by Application (2023-2028)
Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
Table 64. Agilent Technologies Company Details
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies PD-L1 Biomarker Testing Product
Table 67. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 68. Agilent Technologies Recent Developments
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche PD-L1 Biomarker Testing Product
Table 72. Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 73. Roche Recent Developments
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck PD-L1 Biomarker Testing Product
Table 77. Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 78. Merck Recent Developments
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb PD-L1 Biomarker Testing Product
Table 82. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Developments
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca PD-L1 Biomarker Testing Product
Table 87. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 88. AstraZeneca Recent Developments
Table 89. Ono Pharmaceutical Company Details
Table 90. Ono Pharmaceutical Business Overview
Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product
Table 92. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 93. Ono Pharmaceutical Recent Developments
Table 94. Regeneron Company Details
Table 95. Regeneron Business Overview
Table 96. Regeneron PD-L1 Biomarker Testing Product
Table 97. Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 98. Regeneron Recent Developments
Table 99. Innovent Company Details
Table 100. Innovent Business Overview
Table 101. Innovent PD-L1 Biomarker Testing Product
Table 102. Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 103. Innovent Recent Developments
Table 104. Hengrui Medicine Company Details
Table 105. Hengrui Medicine Business Overview
Table 106. Hengrui Medicine PD-L1 Biomarker Testing Product
Table 107. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 108. Hengrui Medicine Recent Developments
Table 109. Junshi Biosciences Company Details
Table 110. Junshi Biosciences Business Overview
Table 111. Junshi Biosciences PD-L1 Biomarker Testing Product
Table 112. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
Table 113. Junshi Biosciences Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 Biomarker Testing Market Share by Type: 2021 VS 2028
Figure 2. PD-L1 (22C3) Features
Figure 3. PD-L1(28-8) Features
Figure 4. PD-L1 (SP142) Features
Figure 5. PD-L1 (SP263) Features
Figure 6. Other Features
Figure 7. Global PD-L1 Biomarker Testing Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Diagnostic Center Case Studies
Figure 10. Others Case Studies
Figure 11. PD-L1 Biomarker Testing Report Years Considered
Figure 12. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global PD-L1 Biomarker Testing Market Share by Region: 2021 VS 2028
Figure 15. Global PD-L1 Biomarker Testing Market Share by Players in 2021
Figure 16. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2021
Figure 18. North America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 20. North America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 21. North America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 22. United States PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 26. Europe PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 27. Europe PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 28. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific PD-L1 Biomarker Testing Market Size Share by Region (2017-2028)
Figure 38. China PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 46. Latin America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 47. Latin America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 48. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
Figure 54. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 58. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 62. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 63. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 64. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 65. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 66. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global PD-L1 Biomarker Testing Market Insights and Forecast to 2028
Agilent TechnologiesRoche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Request Sample
Request Discount
